W
illiam B. Schwartz, one of the golden boys of the golden age of nephrology, died on 15 March 2009 at the age of 86. WBS, as he was known to those of us who worked closely with him, will be long remembered not only for his remarkable contributions to our understanding of the kidney, but also for his pioneering work in decision analysis and, most recently, for his prescient insights into the arcane world of medical economics.
First, nephrology. WBS can be rightfully credited with having been a midwife at the birth of modern nephrology. An Alabama native who got his BA and MD from Duke, he was one of a handful of post-World War II investigators who saw an opportunity to apply the still crude tools of physiology to unravel the mysteries that lay deep within the kidney. Along with such venerable founders of our discipline as Don Seldin at Southwestern, Lou Welt at the UNC, Frank Epstein at Yale, Alex Leaf at Harvard, and especially Arnold 'Bud' Relman at neighboring Boston University, WBS worked his magic at Tufts-New England Medical Center. It was Sam Proger, the legendary chair of medicine at Tufts with an unerring eye for talent, who recognized the promise in the 28-year-old Schwartz and invited him in 1950 to establish a laboratory devoted to the study of this mysterious organ.
Over the next two decades, the Schwartz lab made seminal contributions to the foundational literature in this rapidly developing field. His discovery that sulfanilamide had diuretic properties led to the development of acetazolamide, thiazides, and eventually furosemide. He and Fred Bartter identified the syndrome of inappropriate antidiuretic hormone secretion, a condition still known as SchwartzBartter syndrome. His laboratory defined the whole-body response to both acute and chronic respiratory acidosis and alkalosis, laying the groundwork for distinguishing 'simple' from 'mixed' acid-base disorders. He established the key role of chloride in metabolic alkalosis and, with Relman, described the defect in renal concentrating ability due to potassium depletion and the defects in acid excretion in renal failure. He was also the first to describe spontaneous lactic acidosis. The countless journal articles, reviews, and textbook chapters that WBS authored and coauthored during these halcyon days of nephrology had much to do with setting the standard of scientific rigor and clarity of thought that came to characterize this new field.
WBS was also a prolific educator. He trained some 60 fellows during his tenure as division chief, the great majority of whom went on to assume important leadership roles in academic medicine. The lessons he taught all of his students went far beyond the intricacies of renal function or the arcana of acid-base metabolism. His dedication to scientific integrity, his unflinching demand for solid evidence before reaching a conclusion, and his insistence on the precise use of language are indelibly etched in the psyches of all of us who were privileged to have WBS as a tutor.
In 1971, WBS succeeded Sam Proger as chair of Medicine at Tufts and launched the second phase of his remarkable career. In various collaborations with Jerry Kassirer, Steve Pauker, Tony Gorry, and Al Essig, WBS was among the very first people to recognize the power of formal decision analysis to improve the assessment of complex clinical problems. The still promising field of artificial intelligence owes a sizable debt to these early adopters of Bayesian analysis as a means for removing bias and increasing the accuracy of diagnosis.
In 1976, WBS was named Vannevar Bush University Professor at Tufts University, and in 1992 he joined the faculty of the University of Southern California to facilitate his new collaborations with scholars at the Rand Corporation. It was during these latter decades of his illustrious career that WBS widened his scholarly horizon to encompass the entire health-care system. He and his collaborators contributed incisive analyses of a wide range of pressing issues, including the impact of rising hospital costs, the geographic maldistribution of specialists, and the adverse influence of malpractice insurance.
Arguably the most provocative and farreaching of his views was the prediction that the United States would eventually need to In addition, he wrote innumerable thought pieces for the health-policy community and for the popular press, all of which challenged his readers to grapple with emerging issues that his incomparable intellect recognized more quickly and grasped more clearly than virtually anyone else in the country.
Few can claim to have truly advanced even one field of study. Fewer still, two. Virtually none, three. William B. Schwartz belongs in that last, rarefied group. The fields of nephrology, clinical decision analysis, and health policy all bear the undying stamp of his brilliance. He was intellectually restless, uncompromisingly rigorous, and incessantly curious. We are not likely to see his equal any time soon.
